Items tagged with Advocacy
TB activists disrupt opening of The Union Conference to protest drug corporations keeping life-saving medicines from people (post with simple image)
Newer medicines for drug-resistant TB are desperately needed, but barriers to access, including high prices, keep them out of reach for most people around the world.
Price announced for new lifesaving TB drug pretomanid still too high (post with simple image)
Pretomanid is just one part of a regimen of multiple drugs that people need. MSF has been calling for the price of a complete DR-TB treatment course to be no higher than $500 per person.
Online consultation on the draft Global Plan to End TB (post with simple image)
Stop TB Partnership launches online consultation on the draft Global Plan to End TB 2018-2022; Deadline for submissions: 6 November 2019
Civil society statement on rifapentine price discount (post with simple image)
A lower price for rifapentine is just a start — communities need more than discounts to access TB preventive therapy!
Protestors demand Cepheid halve the price of GeneXpert TB tests to US$5 (post with simple image)
The high cost of GeneXpert tests for TB leaves open a critical gap in the diagnosis of TB and fails to consider volume of sales and public investments in the development of GeneXpert.
Public investments in TB medicine bedaquiline far exceed those of developer Johnson & Johnson (post with simple image)
Quantification of investments in the development of bedaquiline finds total public and philanthropic expenditures are three to five times those of Johnson & Johnson.
Survivors Statement (post with simple image)
Presented in the Opening Ceremony of the 50th Union World Conference on Lung Health by survivor Nandita Venkatesan.
TAG applauds Indian TB activists in opposing patents for critical TB prevention drugs (post with simple image)
Civil society takes legal action to contest patent applications filed by Sanofi on fixed-dose combinations of two decades-old drugs used to prevent TB.
TB Alliance responds to questions raised by activists in relation to pretomanid (post with simple image)
MSF, TAG and TB CAB raised a number of outstanding medical and research questions regarding pretomanid and the regimen BPaL.
New TAG report: Funding for TB research climbed to new high in 2018 (post with simple image)
The report — Tuberculosis Research Funding Trends, 2005–2018 — presents new data on funding for TB research and development in 2018 and analyzes trends in spending since 2005.
Page 105 of 127 · Total posts: 0
←First 104 105 106 Last→